Nluc Reporter Cell Line - B16F10

The B16F10 cell line is a murine melanoma model derived from C57BL/6 mice, widely recognized for its aggressive metastatic behavior and stability in preclinical studies. The F10 subclone was specifically selected from the parental B16 melanoma cell line for its high lung colonization capacity after intravenous injection, making it a gold standard for studying metastatic mechanisms, tumor immunology, and therapeutic interventions. These cells proliferate rapidly in vitro and form highly pigmented tumors in syngeneic mouse models, allowing researchers to study melanoma progression, angiogenesis, and immune evasion. The genetic stability of B16F10 and its compatibility with immunocompetent hosts further enable its use in studying tumor microenvironment interactions, which is crucial for evaluating novel anticancer drugs, immunotherapies, and gene therapies.

The Nluc reporter gene cell line – B16F10 – integrates the Nluc luciferase reporter gene into the B16F10 genome, creating a powerful tool for real-time quantitative tracking of tumor dynamics. This engineered cell line emits strong and sustained bioluminescence upon exposure to the furimazine substrate, allowing for highly sensitive detection of in vivo tumor burden, metastasis, and treatment response using non-invasive imaging systems such as IVIS. Applications include high-throughput drug screening (where the Nluc signal correlates with cell viability and compound efficacy); longitudinal studies of tumor growth and metastasis in live animals, reducing the need for endpoint measurements; and assessing the efficacy of immunotherapies by monitoring immune-mediated tumor regression. The small size and high brightness of the reporter gene also facilitate single-cell tracking, tumor heterogeneity analysis, and co-culture experiments. By providing low-background luminescence readings, the Nluc-B16F10 cell line enhances the accuracy of translational research, accelerates drug development, and supports mechanistic studies of cancer biology and treatment resistance.